Jane Street’s MAIA Biotechnology MAIA Stock Holding History

Jane Street’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78,757	Closed	-$120K	–	12403
2025 Q4	$120K	Buy	+78,757	New	+$103K	﹤0.01%	10078
2025 Q3	–	Sell	-28,783	Closed	-$51.8K	–	11370
2025 Q2	$51.8K	Buy	+28,783	New	+$51.5K	﹤0.01%	9159
2025 Q1	–	Sell	-39,057	Closed	-$77.3K	–	10130
2024 Q4	$77.3K	Buy	+39,057	New	+$93.6K	﹤0.01%	8859
2024 Q3	–	Sell	-11,930	Closed	-$40.8K	–	10079
2024 Q2	$40.8K	Sell	11,930 -13,135	-52%	-$41.4K	﹤0.01%	8960
2024 Q1	$55.1K	Buy	+25,065	New	+$37.6K	﹤0.01%	8717
2022 Q4	–	Sell	-10,210	Closed	-$34K	–	9714
2022 Q3	$34K	Buy	+10,210	New	+$43.2K	﹤0.01%	9058

Other funds holding MAIA

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's MAIA Position: Q1 2026 in Review

Jane Street sold out of MAIA Biotechnology (MAIA) in Q1 2026, closing a stake of 78,757 shares — an estimated $120K sold.

Jane Street first reported a position in MAIA in Q3 2022 and held it in 6 quarters. The position peaked at $120K in Q4 2025. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

Jane Street reported no remaining MAIA Biotechnology position as of Q1 2026 after selling out during the quarter.
Jane Street sold 78,757 MAIA Biotechnology shares in Q1 2026, an estimated $120K.
Jane Street first reported a position in MAIA Biotechnology in Q3 2022 and held it in 6 quarters.
Jane Street's MAIA Biotechnology position peaked at $120K in Q4 2025.
33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.